kth.sePublications KTH
Change search
Link to record
Permanent link

Direct link
Nguyen, Mai Thi HuyenORCID iD iconorcid.org/0009-0002-7680-1464
Publications (2 of 2) Show all publications
Bueno Álvez, M., Bergström, S., Kenrick, J., Johansson, E., Altay, Ö., Sköld, H., . . . et al., . (2025). A human pan-disease blood atlas of the circulating proteome. Science, 390(6779), Article ID eadx2678.
Open this publication in new window or tab >>A human pan-disease blood atlas of the circulating proteome
Show others...
2025 (English)In: Science, ISSN 0036-8075, E-ISSN 1095-9203, Vol. 390, no 6779, article id eadx2678Article in journal (Refereed) Published
Abstract [en]

The human blood proteome provides a holistic readout of health states through the assessment of thousands of circulating proteins. In this study, we present a pan-disease resource to enable the study of diverse disease phenotypes within a harmonized proteomics dataset. By profiling protein concentrations across 59 diseases and healthy cohorts, we identified proteins associated with age, sex, and body mass index, as well as disease-specific signatures. This study highlights shared and distinct protein patterns across conditions, demonstrating the power of a unified proteomics approach to uncover biological insights. The dataset, covering 8262 individuals and up to 5416 proteins, serves as an online resource for exploring disease-specific protein profiles and advancing precision medicine research.

Place, publisher, year, edition, pages
American Association for the Advancement of Science (AAAS), 2025
National Category
Medical Biotechnology (Focus on Cell Biology, (incl. Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
urn:nbn:se:kth:diva-378079 (URN)10.1126/science.adx2678 (DOI)001643421200001 ()41066540 (PubMedID)2-s2.0-105025246161 (Scopus ID)
Note

QC 20260318

Available from: 2026-03-18 Created: 2026-03-18 Last updated: 2026-04-27Bibliographically approved
Möller, V., Welander, J., Nilsson, M., Nguyen, M. T., Holmbom, M., Hanberger, H., . . . Berglund, B. (2025). Virulence factors and outcomes in bacteremia caused by extended-spectrum β-lactamase-producing uropathogenic Escherichia coli ST131-H30Rx in a Swedish county. BMC Infectious Diseases, 25(1), Article ID 1103.
Open this publication in new window or tab >>Virulence factors and outcomes in bacteremia caused by extended-spectrum β-lactamase-producing uropathogenic Escherichia coli ST131-H30Rx in a Swedish county
Show others...
2025 (English)In: BMC Infectious Diseases, E-ISSN 1471-2334, Vol. 25, no 1, article id 1103Article in journal (Refereed) Published
Abstract [en]

Background: Escherichia coli ST131 and clade H30Rx are the most prevalent extended-spectrum β-lactamase-producing E. coli (ESBL-EC) causing bacteremia and urinary tract infections globally and in Sweden. Previous studies have linked ST131-H30Rx with septic shock and mortality, as well as prolonged carriage. In our previous study, ST131 constituted 54% of all ESBL-EC bacteremia originating from the urinary tract. Method: Utilizing whole-genome sequencing, we retrospectively compared virulence factors (VFs) and patient outcomes based on medical records among 77 isolates of ESBL-EC from 76 patients with pyelonephritis between 2009 and 2018 in a Swedish county. Results: The VFs Ibes and uropathogenic specific protein were associated with ST131 of all clades (p < 0.0001). Serine protease (p < 0.0001) and cnf1 (p = 0.0003) were more common among ST131-H30Rx compared to non-ST131 isolates whereas enterobactin and iss were more common among ST131-H30Rx compared to both other ST131 isolates (p < 0.0001 and p = 0.0007, respectively) and non-ST131 isolates (p < 0.0001). Sepsis within 36 h was less common among patients infected with ST131-H30Rx (p = 0.038). Conclusions: ST131-H30Rx isolates carried VFs which were associated with recurrence but not uniformly to sepsis. In this explorative study, our results indicate that the ST131-H30Rx clade are not more prone to cause severe infection than other sequence types, but prone to cause recurrence, in addition to ESBL production which limits treatment options. Further studies are warranted to explore the mechanisms driving the success of ST131-H30Rx isolates in causing recurrent infections and colonization, and to form preventive measures.

Place, publisher, year, edition, pages
Springer Nature, 2025
Keywords
Antimicrobial resistance, Escherichia coli, Extended-spectrum β-lactamase, Sepsis, ST131
National Category
Microbiology in the Medical Area Infectious Medicine
Identifiers
urn:nbn:se:kth:diva-370405 (URN)10.1186/s12879-025-11519-9 (DOI)001568804100001 ()40926251 (PubMedID)2-s2.0-105015375170 (Scopus ID)
Note

QC 20250926

Available from: 2025-09-26 Created: 2025-09-26 Last updated: 2025-09-26Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0009-0002-7680-1464

Search in DiVA

Show all publications